Drug Profile
Neurological disorder therapeutic - Actelion
Alternative Names: Neurology compound - ActelionLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Actelion Pharmaceuticals
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders